Previous Article in Journal
Detection of Human Bladder Epithelial Cancerous Cells with Atomic Force Microscopy and Machine Learning
Previous Article in Special Issue
Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review

State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, School of Marine Sciences, Ningbo University, Ningbo 315211, China
*
Authors to whom correspondence should be addressed.
Cells 2025, 14(1), 15; https://doi.org/10.3390/cells14010015
Submission received: 20 November 2024 / Revised: 19 December 2024 / Accepted: 24 December 2024 / Published: 26 December 2024

Abstract

Ubiquitin-conjugating enzyme E2 T (UBE2T) is a crucial E2 enzyme in the ubiquitin-proteasome system (UPS), playing a significant role in the ubiquitination of proteins and influencing a wide range of cellular processes, including proliferation, differentiation, apoptosis, invasion, and metabolism. Its overexpression has been implicated in various malignancies, such as lung adenocarcinoma, gastric cancer, pancreatic cancer, liver cancer, and ovarian cancer, where it correlates strongly with disease progression. UBE2T facilitates tumorigenesis and malignant behaviors by mediating essential functions such as DNA repair, apoptosis, cell cycle regulation, and the activation of oncogenic signaling pathways. High levels of UBE2T expression are associated with poor survival outcomes, highlighting its potential as a molecular biomarker for cancer prognosis. Increasing evidence suggests that UBE2T acts as an oncogene and could serve as a promising therapeutic target in cancer treatment. This review aims to provide a detailed overview of UBE2T’s structure, functions, and molecular mechanisms involved in cancer progression as well as recent developments in UBE2T-targeted inhibitors. Such insights may pave the way for novel strategies in cancer diagnosis and treatment, enhancing our understanding of UBE2T’s role in cancer biology and supporting the development of innovative therapeutic approaches.
Keywords: UBE2T; ubiquitin-conjugating enzyme; ubiquitin-proteasome system UBE2T; ubiquitin-conjugating enzyme; ubiquitin-proteasome system

Share and Cite

MDPI and ACS Style

Gao, C.; Liu, Y.-J.; Yu, J.; Wang, R.; Shi, J.-J.; Chen, R.-Y.; Yang, G.-J.; Chen, J. Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review. Cells 2025, 14, 15. https://doi.org/10.3390/cells14010015

AMA Style

Gao C, Liu Y-J, Yu J, Wang R, Shi J-J, Chen R-Y, Yang G-J, Chen J. Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review. Cells. 2025; 14(1):15. https://doi.org/10.3390/cells14010015

Chicago/Turabian Style

Gao, Chang, Yan-Jun Liu, Jing Yu, Ran Wang, Jin-Jin Shi, Ru-Yi Chen, Guan-Jun Yang, and Jiong Chen. 2025. "Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review" Cells 14, no. 1: 15. https://doi.org/10.3390/cells14010015

APA Style

Gao, C., Liu, Y. -J., Yu, J., Wang, R., Shi, J. -J., Chen, R. -Y., Yang, G. -J., & Chen, J. (2025). Unraveling the Role of Ubiquitin-Conjugating Enzyme UBE2T in Tumorigenesis: A Comprehensive Review. Cells, 14(1), 15. https://doi.org/10.3390/cells14010015

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop